
A Balanced Life Requires Unbalanced Seasons
Welcome to Effective Habits, a weekly newsletter where I share evidence-based strategies and tools to help you live a happy, healthy, and productive life.
Today at a Glance:
Stop Trying to Be Balanced and Live Life in Seasons Instead
Reducing Cardiovascular Risk: A Playbook for Lipid-Lowering Pharmacotherapy
This Is The Most Important Skill You Can Have In Life
“Narrative is radical, creating us at the very moment it is being created.”

🔦Lights, Camera, ...
The idea that a good life must be perfectly “balanced” is mostly a trap. The happiest and most accomplished people rarely divide their time evenly between work, family, fitness, friends, and everything else; they live in seasons. For a while, a career may take center stage. Then it might be raising young kids, training for a race, falling in love, writing a book, or chasing some other absorbing goal. Going all in inevitably means something else gets less attention, and that’s not a failure—it’s the tradeoff that makes meaningful pursuits possible. The trick is not to neglect the rest of your life completely, but to maintain a minimum effective dose in the areas that still matter: keep the relationships alive, stay reasonably healthy, do enough work to remain sharp. Zoom in on any one season and your life may look wildly unbalanced; zoom out across years or decades and a different picture emerges. Real balance is often sequential, not simultaneous: you can’t give everything your all at once, but over a lifetime, you can give many things their turn.
🎬Action!
Decide what this season of your life is for. Pick the one area that deserves disproportionate attention right now—work, family, fitness, a relationship, a creative project, or something else—and give yourself permission to prioritize it. Then define the minimum effective dose for the other parts of your life so they don’t fall apart: perhaps two workouts a week, one evening with friends, protected family time, or enough work to stay current. Revisit the choice every year or few months. The goal isn’t to balance everything today; it’s to make intentional tradeoffs so that, over years, each important part of your life gets its season.

Reducing Cardiovascular Risk: A Playbook for Lipid-Lowering Pharmacotherapy
Dr. Taylor Yeater, Dr. Tom Dayspring & Dr. Peter Attia
🔦Lights, Camera, ...
Cardiovascular risk is easy to oversimplify because a routine annual physical often stops at the standard lipid panel—total cholesterol, LDL-C, HDL-C, and triglycerides. Those numbers matter, but they don’t tell the whole story. ApoB measures the number of potentially atherogenic particles circulating in your blood, and when ApoB and LDL-C disagree, ApoB can provide a better picture of atherosclerotic risk. Other tests answer different questions: Lp(a) can reveal an important inherited risk factor; metabolic testing can show whether insulin resistance is contributing; imaging can reveal whether plaque is already present; and a sterol panel can help determine whether elevated cholesterol is being driven mainly by increased intestinal absorption, increased cholesterol production, or both. The first priority should still be improving the lifestyle factors you can control—exercise, nutrition, body composition, metabolic health, smoking, and other modifiable risks. But lifestyle and lipid lowering are complementary: if ApoB or overall cardiovascular risk remains high, medication may still be appropriate, particularly for people who already have substantial risk or plaque. The goal is therefore not simply to get an LDL-C result and ask whether it is “good” or “bad,” but to understand your level of risk, what is driving it, and which intervention is most likely to reduce it. The steps below are meant to help you have that discussion with your doctor more informed—not to prescribe treatment yourself.
🎬Action!
Before reaching for medication alone, address the fundamentals: exercise regularly, improve diet quality and energy balance, maintain a healthy body composition, improve insulin sensitivity, avoid smoking, and limit factors such as excessive alcohol that may worsen triglycerides or metabolic health.
Get a complete baseline. Ask your doctor whether your cardiovascular assessment should include:
Standard lipid panel: LDL-C, HDL-C, triglycerides and total cholesterol.
ApoB: estimates the number of potentially atherogenic particles and serves as the main treatment endpoint in this framework.
Lp(a): generally worth measuring at least once because it is largely inherited and can raise cardiovascular risk independently of LDL-C.
Metabolic markers: fasting glucose, fasting insulin and HbA1c; more detailed testing may be useful if insulin resistance is suspected.
hs-CRP: provides additional information about systemic inflammation and cardiovascular risk.
Then agree with your doctor on an ApoB goal based on your overall risk. Someone with established cardiovascular disease, existing plaque, elevated Lp(a), or otherwise high risk generally warrants a more aggressive target than a low-risk person.
For people without known cardiovascular disease, also discuss whether imaging would meaningfully change your treatment. A coronary artery calcium (CAC) scan detects calcified plaque and provides a measure of accumulated atherosclerosis, while coronary CT angiography (CTA) can detect both calcified and non-calcified plaque. CTA may therefore provide additional information in some people, particularly younger patients who can develop plaque before substantial calcification appears.

There is no single “good” ApoB number for everyone. The higher your underlying cardiovascular risk, the more aggressively ApoB is generally lowered.
Deal with urgent or underlying problems first.
If triglycerides are 500 mg/dL or higher, discuss them promptly with your doctor. At that level, the immediate concern includes pancreatitis, so treatment priorities change and secondary causes such as alcohol use, poor glycemic control, medications, thyroid problems, and genetics need to be investigated.
If triglycerides are moderately elevated or testing shows substantial insulin resistance, treat the metabolic problem as part of the cardiovascular problem. Improving nutrition, energy balance, body composition, and insulin sensitivity may lower triglycerides and ApoB enough to change how much medication is ultimately required.
If medication is needed, find out what may be driving the high cholesterol. Instead of automatically defaulting to the same drug for everyone, ask whether a sterol panel would be useful. It measures markers that help distinguish two major contributors to the liver's cholesterol supply:
High sitosterol and campesterol → greater intestinal cholesterol absorption.
High lathosterol and desmosterol → greater cholesterol synthesis by the body.
Both elevated → a mixed pattern.
This matters because many lipid-lowering drugs ultimately help the liver clear more ApoB particles, but they get there through different pathways.
Match the first medication to the dominant pathway with your doctor. If lifestyle changes are insufficient, or your cardiovascular risk warrants medication regardless, the framework proposes:
High absorption → ezetimibe to reduce intestinal cholesterol absorption.
High synthesis → a statin to reduce cholesterol production.
Both pathways elevated → statin + ezetimibe rather than spending months trying one pathway at a time.
Recheck after 6–8 weeks and adjust based on the response. After starting or changing treatment, repeat the measurements that will tell you whether it is working: ApoB and standard lipid panel, Sterol panel, Liver enzymes, Metabolic markers (if there was baseline concern about insulin resistance), and Side effects and tolerability. The goal is not simply to see whether your LDL-C “went down,” but whether you reached your risk-appropriate ApoB target without creating unacceptable side effects or metabolic problems.
If you are still above target, add strategically. If the first treatment helps but doesn’t get you to your target, discuss combining treatments that work through different pathways rather than automatically pushing the dose of one drug higher. Statins, for example, have diminishing returns as their dose increases, while reducing cholesterol synthesis can sometimes cause a compensatory increase in cholesterol absorption—making the addition of ezetimibe more logical in some cases. The broad progression is: Match the first treatment to the dominant pathway → cover both absorption and synthesis if needed → consider a PCSK9-targeting drug if ApoB remains above target. For people who genuinely cannot tolerate statins, alternatives such as bempedoic acid, often paired with ezetimibe, can target cholesterol synthesis through a different mechanism.

Expected LDL-C reductions based on drug class

🔦Lights, Camera, ...
Writing is often treated as a way to communicate what you already know, but its greater value is that it forces you to discover what you actually think. When a young Dwight Eisenhower was asked, days after Pearl Harbor, what America should do next, he didn’t improvise an answer, but asked for a few hours, sat down with paper and a typewriter, and worked his way toward a clear 300-word plan. That slow process of wrestling with ideas, weighing alternatives, finding the right words, and revising until the argument holds together is what makes writing so powerful. It develops not just communication, but focus, patience, judgment, and the ability to think deeply under pressure. That is also why outsourcing the difficult first draft to AI can be such a bad trade: you may get a polished piece of writing faster, but you skip the struggle that would have sharpened your mind. The point of writing, whether it is an essay, memo, journal entry, or argument, isn’t merely the words you end up with—it’s the clearer, more capable thinker you become by having to produce them yourself.
🎬Action!
Use writing to think, not just to communicate. When you’re wrestling with an important decision, idea, or problem, resist the urge to immediately ask AI for the answer. Open a blank page and write your own first pass: define the problem, explain what you think, consider the strongest alternatives, and keep revising until you can express your conclusion clearly. Only then use AI or another person to challenge, edit, or improve it. The rule: do the thinking yourself first, then use AI to sharpen it, not replace it. However, for routine, low-stakes work where you already understand the problem and the main goal is simply to get it done, delegate freely.
TOOL TIP
The True Size Of ...: Drag countries around a map to reveal how dramatically the Mercator projection distorts their apparent size.
FUN FACT
Scientists search for penguin poo from space. Guano stains are visible in satellite images, allowing researchers to locate and monitor remote Antarctic penguin colonies. Seasonal color changes can even help distinguish different species.
If you’ve found value in what I share, buying me a coffee is a great way to say “thanks” and help me keep doing what I love. Every bit of support helps me spend more time creating useful, thoughtful content for you. Thanks for being here—it means a lot! 🙏
If you enjoyed today's newsletter, please share it with your friends and family!
If this email was forwarded to you, consider subscribing to receive them in future!
What'd you think of today's edition?
Disclaimer: The information provided in this newsletter is for informational purposes only and is not intended as medical advice. Please consult a medical professional for advice, diagnosis, or treatment. We are not liable for any risks or issues that may arise from using this information.
